Phase 2 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have locally advanced breast cancer that has not spread to other parts of the body, with a tumor and lymph node involvement that falls within certain specific size and spread categories (confirm with trial site)
- Your breast cancer has been confirmed by a central lab to be either "triple-negative" or a specific low-hormone type that will be treated like triple-negative breast cancer
- If you have Hepatitis B, you may still be eligible if you have been on antiviral treatment for at least 4 weeks and the virus is undetectable in your blood
- If you have a history of Hepatitis C, you may still be eligible if the virus is currently undetectable in your blood
- You are generally well enough to carry out light activity and care for yourself (a standard health rating of 0 or 1 on a medical scale), assessed within the last 28 days
- Your heart is pumping blood effectively, with a pumping function of 50% or above, confirmed by a heart scan
Who may not be able to join:
- You have serious or poorly controlled heart disease
- You have, or have had, cancer that has spread to the lining around the brain or spinal cord
- You have a significant eye or cornea condition
- You have HIV along with a history of a specific HIV-related cancer (Kaposi sarcoma) or a rare immune system disorder (multicentric Castleman disease)
- You have an ongoing, uncontrolled infection caused by bacteria, fungus, or a virus
- You have previously been treated with certain immunotherapy drugs that target the immune system's "checkpoint" pathways (such as anti-PD-1 or anti-PD-L1 therapies)
- You have received any prior treatment for your current breast cancer diagnosis, including radiation, drug therapy, or surgery
- You have previously been treated with certain targeted antibody drugs or a specific type of antibody-drug combination therapy (confirm with trial site)
- Your breast cancer has spread to other parts of the body (Stage IV) or has spread to certain higher-level lymph nodes (confirm with trial site)
- You have another cancer that is still active or has required treatment within the last 5 years
- You have cancer that has spread to your brain or the fluid around your brain or spinal cord
- You have ever had a lung condition called interstitial lung disease or pneumonitis, or are currently suspected of having it
- You currently have an active infection that requires treatment with medication
- You have both Hepatitis B and Hepatitis C infections at the same time
- You have serious breathing difficulties caused by a current lung illness
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Part 1: Number of Participants Experiencing an Adverse Event (AE); Part 1: Number of Participants Who Experience One or More Dose-Limiting Toxicities (DLTs); Part 1: Number of Participants who Discontinued Study Treatment Due to an AE; Part 2: Pathological Complete Response (pCR) Rate Using the Definition of ypT0/Tis ypN0; Part 2: Number of Participants Experiencing an AE; Part 2: Number of Participants who Discontinued Study Treatment Due to an AE
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.